Physician profile
John A Merlino
NPI 1811013246
$15,130.96
in general payments reported to CMS, 2019-2025
24 companies · $6,515 in 2025
The $6,515 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,559 · 2020: $1,074 · 2021: $1,653 · 2022: $706 · 2023: $1,114 · 2024: $1,511 · 2025: $6,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,442 · Travel and Lodging: $3,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,442.21 |
| Travel and Lodging | $3,697.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,055.19 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Boston Scientific Corporation | $4,827.64 | 2019-2025 | Accolade Sr, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $2,995.58 | 2019-2025 | Aveir, Jot Dx, Assurity |
| Medtronic Vascular, INC. | $782.86 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $244.48 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $197.71 | 2020-2022 | |
| Baxter Healthcare | $168.77 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $101.21 | 2021-2025 | |
| Biotronik INC. | $100.08 | 2021-2025 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $97.83 | 2019-2024 | |
| Biosense Webster, INC. | $90.99 | 2019 | |
| Philips North America LLC | $66.78 | 2022-2024 | (5044) Mcot |
| E.R. Squibb & Sons, L.L.C. | $66.18 | 2019-2024 | Eliquis |
| Impulse Dynamics (USA) INC. | $57.93 | 2025 | Optimizer |
| Cvrx, INC. | $55.38 | 2024 | Barostim Neo System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.15 | 2022-2023 | Verquvo |
| Irhythm Technologies, INC. | $35.60 | 2024 | Zio Monitor, Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $28.90 | 2019 | |
| Inspire Medical Systems, INC. | $24.38 | 2025 | Inspire |
| Altathera Pharmaceuticals LLC | $19.75 | 2025 | Sotalol Hydrochloride |
| Lilly USA, LLC | $17.62 | 2025 | Mounjaro |
| Phathom Pharmaceuticals, INC. | $17.29 | 2025 | Voquezna |
| Terumo Medical Corporation | $15.83 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.83 | 2023 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Merlino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.